Godelieve A.M. Tytgat
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Renal and related cancers, Adrenal and Paraganglionic Tumors, Cancer Genomics and Diagnostics
Most-Cited Works
- → Neuroblastoma is composed of two super-enhancer-associated differentiation states(2017)562 cited
- → Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations(2015)548 cited
- → TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors(2015)395 cited
- → Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors(2015)305 cited
- → An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity(2020)302 cited
- → The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology(2020)196 cited
- → Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study(2016)135 cited
- → Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group(2016)119 cited
- → PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma(2008)97 cited
- → 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma(2015)89 cited